Christofer Baldwin Data-verified
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Graduate Assistant
unknown
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Christofer Baldwin's research focuses on tissue engineering, particularly the development of smooth muscle and skeletal muscle tissues. His work explores the challenges and potential strategies for regenerative medicine, including stem cell-based approaches for skeletal muscle regeneration. Baldwin has also investigated targeted drug delivery systems, such as the use of epidermal growth factor receptors for delivering rapamycin to pancreatic cancer cells to inhibit proliferation and induce apoptosis. His scholarly output includes publications in these areas, supported by a citation record reflecting early-career engagement. Baldwin collaborates with researchers from the University of Arkansas at Fayetteville and the University of Arkansas at Little Rock, contributing to a network focused on biomedical and health sciences.
Metrics
- h-index: 2
- Publications: 3
- Citations: 5
Selected Publications
-
Targeted Delivery of Rapamycin via Epidermal Growth Factor Receptors in Pancreatic Cancer Cells Inhibits Cell Proliferation and Induces Apoptosis (2025)
-
The Challenges and Prospects of Smooth Muscle Tissue Engineering (2024)
-
Stem cell‐based strategies for skeletal muscle tissue engineering (2022)
Collaboration Network
Top Collaborators
- Stem cell‐based strategies for skeletal muscle tissue engineering
- The Challenges and Prospects of Smooth Muscle Tissue Engineering
- Targeted Delivery of Rapamycin via Epidermal Growth Factor Receptors in Pancreatic Cancer Cells Inhibits Cell Proliferation and Induces Apoptosis
- Stem cell‐based strategies for skeletal muscle tissue engineering
- Stem cell‐based strategies for skeletal muscle tissue engineering
- The Challenges and Prospects of Smooth Muscle Tissue Engineering
- Targeted Delivery of Rapamycin via Epidermal Growth Factor Receptors in Pancreatic Cancer Cells Inhibits Cell Proliferation and Induces Apoptosis
- Targeted Delivery of Rapamycin via Epidermal Growth Factor Receptors in Pancreatic Cancer Cells Inhibits Cell Proliferation and Induces Apoptosis
- Targeted Delivery of Rapamycin via Epidermal Growth Factor Receptors in Pancreatic Cancer Cells Inhibits Cell Proliferation and Induces Apoptosis
- Targeted Delivery of Rapamycin via Epidermal Growth Factor Receptors in Pancreatic Cancer Cells Inhibits Cell Proliferation and Induces Apoptosis
- Targeted Delivery of Rapamycin via Epidermal Growth Factor Receptors in Pancreatic Cancer Cells Inhibits Cell Proliferation and Induces Apoptosis
- Targeted Delivery of Rapamycin via Epidermal Growth Factor Receptors in Pancreatic Cancer Cells Inhibits Cell Proliferation and Induces Apoptosis
Similar Researchers
Based on overlapping research topics